Loading data for APN.JO — first visit, this takes a few seconds.

Aspen Pharmacare Holdings Limited (APN.JO)

Johannesburg: APN.JO · Real-Time Price · USD

15,830.00

-37.00 (-0.23%)

At close: Sep 02, 2026, 10:03 AM

Alert

The price, the headline numbers and the latest news, in one place.

-0.23% (1D)

Bid	15836
Market Cap	69.3B
Revenue (ttm)	42.6B
Net Income (ttm)	-1.81B
	0.40
	-4.07
	n/a
	13.02
P/B (ttm)	0.86
P/S (ttm)	1.63
Earnings Date	Sep 2, 2026

Ask	15830
Volume	1,232,864
Avg. Volume (20D)	1,161,309
Open	15643.00
Previous Close	15867.00
Day's Range	15496.00 - 15900.00
52-Week Range	9070.00 - 16079.00
Analyst	n/a
Price Target	n/a
Dividends	$2.11 (1.33%)
Ex-Dividend Date	Oct 1, 2025

About APN.JO

Aspen Pharmacare Holdings Limited, together with its subsidiaries, operates as a specialty and branded pharmaceutical company in Africa, the Middle East, Europe, CIS, Australasia, Asia, and the Americas. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers sterile products in injectable form primarily administered in hospitals and prescribed and administered by physicians or in a retail pharmacy environmen...

Sector Healthcare

IPO Date Jan 4, 2000

Employees 9,128

Stock Exchange Johannesburg

Ticker Symbol APN.JO

Website https://www.aspenpharma.com

Full Company Profile

Financial Performance

In 2025, Aspen Pharmacare s's revenue was 43.36B, a decrease of -3% compared to the previous year's 44.71B. Earnings were -1.08B, a decrease of -124.59%.

Financial numbers in ZAc Financial Statements

Earnings Surprise

Aspen Pharmacare s has released their quarterly earnings on Invalid Date:

Revenue of n/a misses estimates by $0, with NaN% YoY growth.
EPS of misses estimates by , with NaN% YoY growth.

Next Earnings Release

Aspen Pharmacare Holdings Limited is scheduled to release its earnings on Sep 2, 2026, during market hours.
Analysts project revenue of ... Upgrade

Why Price Moved

News

5 months ago · Simply Wall St.

Aspen Pharmacare Holdings Insider Ups Holding During Year

From what we can see, insiders were net buyers in Aspen Pharmacare Holdings Limited's ( JSE:APN ) during the past 12...

6 months ago · GuruFocus.com

Private Credit Giants Back A$1.4 Billion BGH Loan for Aspen Asia Deal

Goldman Sachs Asset Management, Blackstone and Apollo are set to fund covenant-lite financing for BGH's acquisition of Aspen Pharmacare's Asia Pacific operations.